Franklin Resources
BHVN

Franklin Resources’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Franklin Resources’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,604
Closed -$242K – 2432
2022
Q3 		$242K Buy
+1,604
New +$238K ﹤0.01% 1935
2022
Q2 		– Sell
-1,916
Closed -$228K – 2535
2022
Q1 		$228K Buy
+1,916
New +$239K ﹤0.01% 2110
2019
Q3 		– Sell
-289,300
Closed -$12.7M – 1607
2019
Q2 		$12.7M Buy
+289,300
New +$16.3M 0.01% 842

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

Franklin Resources's BHVN Position: Q4 2022 in Review

Franklin Resources sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 1,604 shares — an estimated $242K sold.

Franklin Resources first reported a position in BHVN in Q2 2019 and held it in 3 quarters. The position peaked at $12.7M in Q2 2019. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Franklin Resources reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Franklin Resources sold 1,604 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $242K.
  • Franklin Resources first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2019 and held it in 3 quarters.
  • Franklin Resources's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $12.7M in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Franklin Resources's 13F filing for Q4 2022, filed 10 Feb 2023.